Clinical Trials Directory

Trials / Sponsors / Avidity Biosciences, Inc.

Avidity Biosciences, Inc.

Industry · 10 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationGlobal Open-Label Extension Study of Del-desiran for the Treatment of DM1
Myotonic Dystrophy Type 1, DM1, Myotonic Dystrophy
Phase 32025-07-25
RecruitingA Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy
Phase 32025-06-10
Enrolling By InvitationPhase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FS
FSHD, FSHD1, FSHD2
Phase 22024-07-25
Active Not RecruitingGlobal Study of Del-desiran for the Treatment of DM1
DM1, Myotonic Dystrophy, Myotonic Dystrophy 1
Phase 32024-05-30
Active Not RecruitingPh2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44
DMD, Duchenne Muscular Dystrophy, Duchenne
Phase 22024-01-22
Active Not RecruitingPhase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
FSHD, FSHD1, FSHD2
Phase 1 / Phase 22023-04-04
CompletedStudy of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutation
Duchenne Muscular Dystrophy, Exon 44
Phase 1 / Phase 22022-11-09
CompletedExtension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
DM1, Muscular Dystrophies, Myotonic Dystrophy
Phase 22022-08-04
CompletedStudy of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients
DM1, Myotonic Dystrophy 1, Myotonic Dystrophy
Phase 1 / Phase 22021-10-28
AvailableManaged Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping
Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases
——